Active Ingredient History
Gefapixant (MK-7264) is a drug which acts as an antagonist of the P2RX3 receptor, and may be useful in the treatment of chronic cough. It was named in honour of Geoff Burnstock. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Asthma (Phase 1)
Cough (Phase 3)
Cystitis, Interstitial (Phase 2)
Healthy Volunteers (Phase 1)
Idiopathic Pulmonary Fibrosis (Phase 2)
Osteoarthritis, Knee (Phase 2)
Pain (Phase 2)
Renal Insufficiency (Phase 1)
Sleep Apnea, Obstructive (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue